Investigations of Pharmacologic Properties of the Renal CLC-K1 Chloride Channel Co-expressed with Barttin by the Use of 2-(p-Chlorophenoxy)Propionic Acid Derivatives and Other Structurally Unrelated Chloride Channels Blockers

Journal of the American Society of Nephrology

Volumn 15, Issue 1, 2004, Pages 13-20

  Liantonio, Antonella ^a   Pusch, Michael ^b   Picollo, Alessandra ^b   Guida, Patrizia ^b   De Luca, Annamaria ^a   Pierno, Sabata ^a   Fracchiolla, Giuseppe ^a   Loiodice, Fulvio ^a   Tortorella, Paolo ^a   Conte Camerino, Diana ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 CHLOROPHENOXY)PROPIONIC ACID; 4 ACETAMIDO 4' ISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; 9 ANTHROIC ACID; BARTTIN; BENZOIC ACID DERIVATIVE; BENZYL DERIVATIVE; CARBENE; CHLORIDE; CHLORIDE CHANNEL; CHLORIDE CHANNEL BLOCKING AGENT; CHLORINE; DIURETIC AGENT; EFENAMIC ACID; IMINODIBENZOIC ACID; METHYL GROUP; NIFLUMIC ACID; OXYGEN; PROPIONIC ACID DERIVATIVE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHANNEL GATING; CHEMICAL MODIFICATION; CHIRALITY; CHLORIDE CHANNEL CLC K1; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG UTILIZATION; ELIMINATION REACTION; EXTRACELLULAR SPACE; KIDNEY CONCENTRATING CAPACITY; MICROELECTRODE; NONHUMAN; OOCYTE; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SODIUM ABSORPTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; TECHNIQUE; VOLTAGE CLAMP; WILD TYPE; XENOPUS;

EID: 9144241252     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000103226.28798.EA     Document Type: Article

References (27)

1. Jentsch TJ, Stein V, Weinreich F, Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev 82:503-568, 2002
2. Lourdel S, Paulais M, Marvao P, Nissant A, Teulon J: A chloride channel at the basolateral membrane of the distal-convoluted tubule: A candidate ClC-K channel. J Gen Physiol 121: 287-300, 2003
3. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP: Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17: 171-178, 1997
4. Matsumura Y, Uchida S, Kondo Y, Miyazaki H, Ko SB, Hayama A, Morimoto T, Liu W, Arisawa M, Sasaki S, Marumo F: Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 21: 95-98, 1999
5. Akizuki N, Uchida S, Sasaki S, Marumo F: Impaired solute accumulation in inner medulla of CLCNK1 -/-mice kidney. Am J Physiol 280: F79-F87, 2001
6. Sage CL, Marcus DC: Immunolocalization of CLC-K chloride channels in strial marginal cells and vestibular dark cells. Hear Res 160: 1-9, 2001
7. Estévez R, Boettger T, Stein V, Birkenhäger R, Otto E, Hildebrandt F, Jentsch TJ: Barttin is a Cl channel beta-subunit crucial for renal Cl reabsorption and inner ear K secretion. Nature 414: 558-561, 2001
8. Birkenhäger R, Otto E, Schurlnann MJ, Vollmer M, Ruf E-M Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NVAM, Antignac C, Sudbrak R, Kispert A, Hildebrandt F: Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29: 310-314, 2001
9. Waldegger S, Jeck N, Barth P, Peters M, Vitzthum H, Wolf K, Kurtz A, Konrad M, Seyberth HW: Barttin increases surface expression and changes current properties of CLC-K channels. Pflügers Arch 444: 411-418, 2002
10. Hayama A, Rai T, Sasaki S, Uchida S: Molecular mechanisms of Bartter's syndrome caused by mutations in the BSND gene. Histochem Cell Biol 119: 485-493, 2003
11. Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A, Conte Camerino D, Pusch M: Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid. Mol Pharmacol 62: 265-271, 2002
12. Conte Camerino D, Mambrini M, De Luca A, Tricarico D., Bryant SH, Tortorella V, Bettoni G: Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels. Pflügers Arch 413: 105-107, 1988
13. Pusch M, Liantonio A, Bertorello L, Accardi A, De Luca A, Pierno S, Tortorella V, Conte Camerino D: Pharmacological characterization of the chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol Pharmacol 58: 498-507, 2000
14. Uchida S, Sasaki S, Furukawa T, Hiraoka M, Imai T, Hirata Y, Marumo F: Molecular cloning of a chloride channel that is regulated by dehydration and expressed predominantly in kidney. J Biol Chem 268: 3821-3824, 1993
15. Bettoni G, Loiodice F, Tortorella V, Conte Camerino D, Mambrini M, Ferrannini E, Bryant SH: Stereospecificity of the chloride ion channel: The action of chiral clofibric acid analogues. J Med Chem 30: 1267-1270, 1987
16. Bettoni G, Ferorelli S, Loiodice F, Tangari N, Tortorella V, Gasparrini F, Misiti D, Villani C: Chiral α-substituted α-aryloxyacetic acids: Synthesis, absolute configuration, chemical resolution, and direct separation by HPLC. Chirality 4: 193-203, 1992
17. Calleri E, Massolini G, Loiodice F, Fracchiolla G, Temporini C, Felix G, Tortorella P, Caccialanza G: Evaluation of a penicillin G acylase-based chiral stationary phase towards a series of 2-aryloxyalkanoic acids, isosteric analogs and 2-arylpropionic acids. J Chromatography A 958: 131-140, 2002
18. Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Conte Camerino D, De Luca A, Liantonio A: Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid. Farmaco 56: 749-754, 2001
19. Liantonio A, De Luca A, Pierno S, Didonna MP, Loiodice F, Fracchiolla G, Tortorella P, Laghezza A, Bonerba E, Traverso S, Elia L, Picollo A, Pusch M, Conte Camerino D: Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1. Br J Pharmacol 139: 1255-1264, 2003
20. Fracchiolla G: New clofibric acid analogues with potential activity on PPARs [Abstract]. XXI Corso avanzato in chimica farmaceutìca e semìnario nazionale per dottorandi, 1-5 Luglio. Urbino, Italy, 2001
21. Waldegger S, Jentsch TJ: Functional and structural analysis of CIC-K chloride channels involved in renal disease. J Biol Chem 275: 24527-24533, 2000
22. Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R: X-ray structure of a CIC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature (Lond) 415: 287-294, 2002
23. Dutzler R, Campbell EB, MacKinnon R: Gating the selectivity filter in CIC chloride channels. Science 300: 108-112, 2003
24. Gatto C, Lutsenko S, Kaplan JH: Chemical modification with dihydro-4, 4′-diisothiocyanostilbene-2, 2′-disulfonate reveals the distance between K480 and K501 in the ATP-binding domain of the Na, K-ATPase. Arch Biochem Biophys 340: 90-100, 1997
25. Okubo K, Kang D, Hamasaki N, Jennings MIL: Red blood cell band 3. Lysine 539 and lysine 851 react with the same H2DIDS (4,4′ -diisothiocyanodihydrostilbene-2, 2′-disulfonic acid) molecule. J Biol Chem 269: 1918-1926, 1994
26. - channel blockers in the thick ascending limb of the loop of Henle. Structure activity relationship. Pflugers Arch 407: S128-S141, 1986
27. Estévez R, Schroeder BC, Accardi A, Jentsch TJ, Pusch M: Conservation of chloride channel structure revealed by an inhibitor binding site in CIC-1. Neuron 38: 47-59, 2003